Teleflex Incorporated
NYSE:TFXMedical - Instruments & Supplies
+$1.04 today
- Market cap
- $6.58B
- Beta
- 0.82
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$22.79
- Dividend yield
- 1.08%
Volume 1.16M
Average 0.80M
TFX Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Teleflex IncorporatedNYSE: TFX
Gross Profit · Q2 FY2026 · quarter ended Jun 2026
Gross profit declines year over year
Q2 FY2026 gross profit of $331.71M fell 23.1% year over year, behind the -17.3% change in trailing-twelve-month gross profit. Sequentially, it rose 7.9% from the prior quarter. Over 3 fiscal years it compounded at -9.9% a year.
Context
- Gross profit amounted to 56.2% of revenue in FY2025, up 0.4 pp from a year earlier.
- Gross profit increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -23.1% toward the trailing-twelve-month pace of -17.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 1.12B USD
- Year-over-year change
- -34.2%
- 4-year CAGR
- -7.8%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.12B | -34.2% |
| FY2024 | 2024-12-31 | 1.7B | +3.4% |
| FY2023 | 2023-12-31 | 1.65B | +7.6% |
| FY2022 | 2022-12-31 | 1.53B | -1.2% |
| FY2021 | 2021-12-31 | 1.55B | — |
Gross Profit vs competitors
How TFX compares with its peers on the latest reported figures
- Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -17.3% is the 9th highest of 11, against a peer median of +11.0%.
- Gross profit amounts to 53.8% of revenue for TFX, versus a peer median of 82.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.04B USD | +9.3% | +7.5% | 57.2% | |
| LTM Sep 2026 | $1.45B USD | +11.0% | +12.7% | 82.9% | |
| LTM Jun 2026 | $1.4B USD | -17.3% | -9.9% | 53.8% | |
| LTM Jun 2026 | $828.57M USD | -51.6% | +36.4% | 82.1% | |
| LTM Sep 2026 | $796.04M USD | +11.3% | +12.4% | 49.4% | |
| LTM Sep 2026 | $742.84M USD | +63.7% | +489.2% | 82.7% | |
| LTM Sep 2026 | $449.02M USD | -45.9% | +25.3% | 99.6% | |
| LTM Jun 2026 | $411.14M USD | +22.6% | — | 93.3% | |
| LTM Jun 2026 | €356.38M EUR | +11.0% | +1.1% | 29.2% | |
| LTM Jun 2026 | -$865K USD | +82.7% | — | — | |
| LTM Sep 2026 | -$140.69M USD | -4.7% | — | 558.9% | |
| Peer median (excluding TFX) | — | +11.0% | +12.7% | 82.7% | |
Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.81B | 2.79B | 2.97B | 3.05B | 1.99B |
| Cost of Revenue | 1.26B | 1.26B | 1.33B | 1.34B | 871.96M |
| Gross Profit | 1.55B | 1.53B | 1.65B | 1.7B | 1.12B |
| Gross Margin | 55.2% | 54.9% | 55.4% | 55.9% | 56.2% |
| Research & Development | 130.84M | 153.82M | 154.35M | 161.67M | 144.78M |
| Selling, General & Admin | 860.09M | 863.75M | 929.87M | 995.27M | 720.17M |
| Operating Expenses | 921.51M | 1.03B | 1.14B | 1.55B | 864.95M |
| Depreciation & Amortization | 237.36M | 230.59M | 242.12M | 274.6M | 177.74M |
| EBITDA | 853.8M | 730.77M | 761.21M | 433.62M | 302.51M |
| EBITDA Margin | 30.4% | 26.2% | 25.6% | 14.2% | 15.2% |
| Operating Income | 628.1M | 499.73M | 506.31M | 151.01M | 255.8M |
| Operating Margin | 22.4% | 17.9% | 17.0% | 5.0% | 12.8% |
| Interest Income | 1.33M | 912K | 12.78M | 8.01M | 6.4M |
| Interest Expense | 56.97M | 54.26M | 85.08M | 83.54M | 100.22M |
| Other Income / Expenses | (68.63M) | (53.81M) | (72.3M) | (75.54M) | (231.25M) |
| Income Before Tax | 559.47M | 445.92M | 434.01M | 75.48M | 24.55M |
| Pre-Tax Margin | 19.9% | 16.0% | 14.6% | 2.5% | 1.2% |
| Income Tax Expense | 74.35M | 83M | 76.44M | 5.32M | (33.98M) |
| Net Income | 485.37M | 363.14M | 356.33M | 69.68M | (905.64M) |
| Net Margin | 17.3% | 13.0% | 12.0% | 2.3% | -45.4% |
| EPS (Basic) | 10.38 | 7.74 | 7.58 | 1.49 | (20.30) |
| EPS (Diluted) | 10.23 | 7.68 | 7.53 | 1.48 | (20.25) |
| Weighted Avg Shares | 46.77M | 46.9M | 46.98M | 46.84M | 44.62M |
| Weighted Avg Shares (Diluted) | 47.43M | 47.31M | 47.3M | 47.09M | 44.72M |
Teleflex Incorporated
NYSE:TFX
Intrinsic Alpha fair value
Locked
Current Price
$165.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.